Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Clinical trial NCT07723261 · RECRUITING
Trial details
- NCT number
- NCT07723261
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-30
- Primary completion
- 2029-03-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.